Atypical TRAV1-2- T cell receptor recognition of the antigen-presenting molecule MR1

Wael Awad, Erin W. Meermeier, Maria L. Sandoval-Romero, Jerome Le Nours, Aneta H. Worley, Megan D. Null, Ligong Liu, James McCluskey, David P. Fairlie, David M. Lewinsohn, Jamie Rossjohn

Research output: Contribution to journalArticleResearchpeer-review

Abstract

MR1 presents vitamin B-related metabolites to mucosal associated invariant T (MAIT) cells, which are characterized, in part, by the TRAV1-2+ αβ T cell receptor (TCR). In addition, a more diverse TRAV1-2- MR1-restricted T cell repertoire exists that can possess altered specificity for MR1 antigens. However, the molecular basis of how such TRAV1-2- TCRs interact with MR1-antigen complexes remains unclear. Here, we describe how a TRAV12-2+ TCR (termed D462-E4) recognizes an MR1-antigen complex. We report the crystal structures of the unliganded D462-E4 TCR and its complex with MR1 presenting the riboflavin-based antigen 5-OP-RU. Here, the TRBV29-1 β-chain of the D462-E4 TCR binds over the F'-pocket of MR1, whereby the complementarity-determining region (CDR) 3β loop surrounded and projected into the F'-pocket. Nevertheless, the CDR3β loop anchored proximal to the MR1 A'-pocket and mediated direct contact with the 5-OP-RU antigen. The D462-E4 TCR footprint on MR1 contrasted that of the TRAV1-2+ and TRAV36+ TCRs' docking topologies on MR1. Accordingly, diverse MR1-restricted T cell repertoire reveals differential docking modalities on MR1, thus providing greater scope for differing antigen specificities.

Original languageEnglish
Pages (from-to)14445-14457
Number of pages13
JournalJournal of Biological Chemistry
Volume295
Issue number42
DOIs
Publication statusPublished - 16 Oct 2020

Keywords

  • Antigen presentation
  • atypical MAIT TCR
  • crystal structure
  • immunology
  • MAIT
  • major histocompatibility complex (MHC)
  • MHC-related molecule (MR1)
  • protein structure
  • receptor structure-function
  • T-cell receptor (TCR)
  • ARC Centre of Excellence in Advanced Molecular Imaging

    Whisstock, J. (Primary Chief Investigator (PCI)), Abbey, B. (Chief Investigator (CI)), Nugent, K. A. (Chief Investigator (CI)), Quiney, H. M. (Chief Investigator (CI)), Godfrey, D. I. (Chief Investigator (CI)), Heath, W. (Chief Investigator (CI)), Fairlie, D. (Chief Investigator (CI)), Chapman, H. (Partner Investigator (PI)), Peele, A. (Partner Investigator (PI)), Davey, J. (Partner Investigator (PI)) & Wittmann, A. (Project Manager)

    30/06/1431/03/21

    Project: Research

Cite this